TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from INVO Fertility ( (IVF) ) is now available.
On June 25, 2025, INVO Fertility, Inc. held its annual meeting of stockholders where several proposals were voted on, except for proposal 3. The meeting was adjourned and later reconvened on July 9, 2025, but was again adjourned to July 23, 2025, to address proposal 3, with the meeting set to be held virtually.
The most recent analyst rating on (IVF) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score reflects significant financial and technical challenges. The company’s financial performance is marred by losses and high leverage, while technical indicators signal negative momentum. Additionally, valuation metrics highlight market concerns about future profitability.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
INVO Fertility, Inc. operates in the fertility industry, providing innovative fertility treatment solutions and services.
Average Trading Volume: 2,493,079
Technical Sentiment Signal: Sell
Current Market Cap: $1.84M
For an in-depth examination of IVF stock, go to TipRanks’ Overview page.